Rapid Diagnostics Market Rapid Diagnostics Market | Page 2

https://www.millioninsights.com/industry-reports/rapid-diagnostics-market/request-sample
Based on end-users, home care settings, hospitals and clinics, clinical diagnostic laboratories, and others could
classify rapid diagnostics in the forecast period. Hospital and clinics sector accounted for the significant share of
the market and is estimated to continue with its dominance in the years to come. The reason could be enhanced
operations at point-of-care (POC) and provide enhanced patient care.
Globally, North America accounted for the substantial share of rapid diagnostics market and is estimated to lead
the overall market in the years to come. The reason behind the overall market growth could be the growing
occurrence of lifestyle diseases, a government initiative to support the acceptance of POC, the presence of
developed healthcare infrastructure, and the rising number of product approvals. The United States is a major
consumer of rapid diagnostics in this region.
Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the
second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest
CAGR in the forecast period. The developing countries like India and China are the major consumers of rapid
diagnostics in this region. The key players of rapid diagnostics market are Siemens Healthcare, Abbott, F.
Hoffmann-La Roche, BD, Danaher, and bioMérieux. These players are concentrating on inorganic growth to
sustain themselves amidst fierce competition.
Browse Related Category Market Reports @
https://www.millioninsights.com/industry/medical-devices